UBS AM’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,344
Closed -$414K 2700
2023
Q2
$414K Hold
2,344
﹤0.01% 2378
2023
Q1
$414K Hold
2,344
﹤0.01% 2378
2022
Q4
$906K Buy
2,344
+14
+0.6% +$5.41K ﹤0.01% 1891
2022
Q3
$785K Buy
2,330
+777
+50% +$262K ﹤0.01% 2109
2022
Q2
$511K Hold
1,553
﹤0.01% 2305
2022
Q1
$679K Hold
1,553
﹤0.01% 2336
2021
Q4
$681K Hold
1,553
﹤0.01% 2411
2021
Q3
$864K Sell
1,553
-134
-8% -$74.5K ﹤0.01% 2246
2021
Q2
$867K Buy
1,687
+4
+0.2% +$2.06K ﹤0.01% 2284
2021
Q1
$1.32M Buy
1,683
+28
+2% +$21.9K ﹤0.01% 1951
2020
Q4
$901K Hold
1,655
﹤0.01% 2043
2020
Q3
$758K Buy
1,655
+685
+71% +$314K ﹤0.01% 1953
2020
Q2
$597K Buy
970
+89
+10% +$54.8K ﹤0.01% 2041
2020
Q1
$419K Sell
881
-57
-6% -$27.1K ﹤0.01% 2039
2019
Q4
$544K Buy
938
+48
+5% +$27.8K ﹤0.01% 2199
2019
Q3
$586K Buy
890
+427
+92% +$281K ﹤0.01% 2206
2019
Q2
$358K Sell
463
-331
-42% -$256K ﹤0.01% 2346
2019
Q1
$561K Buy
794
+436
+122% +$308K ﹤0.01% 2066
2018
Q4
$168K Sell
358
-228
-39% -$107K ﹤0.01% 2441
2018
Q3
$505K Hold
586
﹤0.01% 2082
2018
Q2
$404K Buy
+586
New +$404K ﹤0.01% 2189
2017
Q4
Sell
-3,962
Closed -$1.95M 2606
2017
Q3
$1.95M Hold
3,962
﹤0.01% 1416
2017
Q2
$2.19M Sell
3,962
-3,969
-50% -$2.2M ﹤0.01% 1329
2017
Q1
$5.25M Buy
+7,931
New +$5.25M 0.01% 1008
2016
Q2
Sell
-300
Closed -$67K 2642
2016
Q1
$67K Hold
300
﹤0.01% 2602
2015
Q4
$182K Buy
+300
New +$182K ﹤0.01% 2559